PEARSON J EDWARD 4

Accession 0001437749-23-007815

CIK 0001095565other

View on SEC.gov Company Profile

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 4:26 PM ET

Size

18.2 KB

Accession

0001437749-23-007815

Insider Transaction Report

Form 4

Period: 2023-03-23

HEALTHSTREAM INCHSTM

PEARSON J EDWARD

Senior Vice President

Transactions

Exercise/Conversion
Restricted Share Units
2023-03-23−1,143→ 3,716 total
Exercise: $0.00→ Common Stock (1,143 underlying)
Tax Payment
Common Stock Holding
2023-03-23$26.25/sh−3,896$102,270→ 200,315 total
Exercise/Conversion
Restricted Share Units
2023-03-23−10,500→ 0 total
Exercise: $0.00→ Common Stock (10,500 underlying)
Exercise/Conversion
Restricted Share Units
2023-03-23−1,667→ 0 total
Exercise: $0.00→ Common Stock (1,667 underlying)
Exercise/Conversion
Common Stock Holding
2023-03-23+16,000→ 204,211 total
Exercise/Conversion
Restricted Share Units
2023-03-23−1,719→ 2,005 total
Exercise: $0.00→ Common Stock (1,719 underlying)
Exercise/Conversion
Restricted Share Units
2023-03-23−971→ 5,500 total
Exercise: $0.00→ Common Stock (971 underlying)

Footnotes (9)

[F1]Shares acquired on vesting of restricted share units.
[F2]Shares withheld for payment of tax liability.
[F3]Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
[F4]Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria are established on an annual basis by the Compensation Committee of the Board of Directors. Up to 10% vest on March 15, 2019 for the period January 1, 2018 through December 31, 2018; up to 15% vest on March 15, 2020 for the period January 1, 2019 through December 31, 2019; up to 20% vest on March 15, 2021 for the period January 1, 2020 through December 31, 2020; up to 25% vest on March 15, 2022 for the period January 1, 2021 through December 31, 2021; and up to 30% vest on March 15, 2023 for the period January 1, 2022 through December 31, 2022. Vesting is determined based on actual performance. The performance criteria for the period January 1, 2022 through December 31, 2022 was achieved; therefore 35% of the awards vested on March 15, 2023.
[F5]Not applicable.
[F6]The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 15, 2020, 20% vest on March 15, 2021, 30% vest on March 15, 2022, and the remaining 35% vest on March 15, 2023.
[F7]The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 11, 2021, 20% vest on March 11, 2022, 30% vest on March 11, 2023, and the remaining 35% vest on March 11, 2024.
[F8]The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 17, 2022, 20% vest on March 17, 2023, 30% vest on March 17, 2024, and the remaining 35% vest on March 17, 2025.
[F9]The RSUs are subject to a four year vesting schedule, contingent upon continued service at the time of vesting. 15% vest on March 23, 2023, 20% vest on March 23, 2024, 30% vest on March 23, 2025, and the remaining 35% vest on March 23, 2026.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4 - PEARSON

Issuer

HEALTHSTREAM INC

CIK 0001095565

→

Entity typeother

Related Parties

filerCIK 0001249921

Filing Metadata

Form type: 4
Filed: Mar 23, 8:00 PM ET
Accepted: Mar 24, 4:26 PM ET
Size: 18.2 KB

View on SEC.gov